Horizon Therapeutics Public Lim Price Today
Horizon Therapeutics Public Lim
HZNP
Healthcare
$22.92B
๐ฐ
Market Cap
63.4
๐ธ
Price to Earnings
$1.6
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Hold Consensus
Buy |
3 |
Strong Buy |
3 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
HZNP Price Forecast Target
100.1 ๐ 116.5 +16%
HZNP EPS Forecast
1.6 ๐ 6.8 +328%
Financials
Profit Margin
10 %
Revenue Growth
-6.0 %
Dividend
$ 0
Held Percent
1.2% - Insiders
100.9% - Institutions
-2.1% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $2.4B
-
๐ฐ Blackrock Inc. $1.6B
-
๐ฐ Avoro Capital Advisors LLC $764.0M
-
๐ฐ Pentwater Capital Management Lp $665.8M
-
๐ฐ JP Morgan Chase & Company $598.8M
Stock Ideas
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While littโฆGeorge Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the worldโฆElon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extrโฆDaniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. โฆ๐ฎFAQ
Some Frequently Asked Questions.
The Horizon Therapeutics Public Lim industry is Drug ManufacturersโGeneral
The Horizon Therapeutics Public Lim sector is Healthcare
The Horizon Therapeutics Public Lim forecasted predicted Price to Earnings PE ratio is 14.8
The Horizon Therapeutics Public Lim Price to Earnings PE ratio is 63.4
The Market Capitalization of Horizon Therapeutics Public Lim is $22.92B
There are total of 223596695 float shares with 100.9% held by Institutions and 1.2% held by insiders
The MHorizon Therapeutics Public Lim forecasted Earnings per Share EPS is $6.8
The Horizon Therapeutics Public Lim Earnings per Share EPS is 1.6
The Horizon Therapeutics Public Lim company has $2800556000 gross profits with 10 profit margins
The Horizon Therapeutics Public Lim Earnings Growth is -0.736% with -0.732% quarterly earnings growth
The Horizon Therapeutics Public Lim Revenue is $3575857920 with -0.06 revenue growth
The price target for Horizon Therapeutics Public Lim stock is $116.5 for the high target and $116.5 for the low target
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, with the following breakdown:
- Buy: 3
- Strong Buy: 3
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of Horizon Therapeutics Public Lim is 1.1
The dividend of Horizon Therapeutics Public Lim is $0
The dividend yield of Horizon Therapeutics Public Lim is 0%
The biggest institutional and mutual fund holders of Horizon Therapeutics Public Lim stock are
- Vanguard Group Inc
- Blackrock Inc.
- Avoro Capital Advisors LLC
- Pentwater Capital Management Lp
The Horizon Therapeutics Public Lim ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0